Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
Next-generation Sequencing03:00

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Human Virome01:26

Human Virome

The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone for Treating Female Sexual Dysfunction.

Clinical obstetrics and gynecology·2024
Same author

Independent conclusions?

Climacteric : the journal of the International Menopause Society·2023
Same author

Managing the menopause: the question of evidence.

Climacteric : the journal of the International Menopause Society·2021
Same author

TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial.

Menopause (New York, N.Y.)·2020
Same author

Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR).

Menopause (New York, N.Y.)·2020
Same author

Physical characteristics and properties of estradiol softgel vaginal inserts.

Menopause (New York, N.Y.)·2019
Same journal

Urinary and vaginal symptoms in postmenopausal women: a cross-sectional online survey of Greek women.

Maturitas·2026
Same journal

Association between TyG-FI and depressive symptom trajectories in middle-aged and older adults: interaction with cognitive function and mediation analysis of sleep quality.

Maturitas·2026
Same journal

Intrinsic capacity and the trajectory of ischemic heart disease and its complications: the mediating role of insulin resistance indices.

Maturitas·2026
Same journal

Mobility limitation trajectories and longitudinal changes in delayed recall in midlife and later life: A multicohort study.

Maturitas·2026
Same journal

Digital twins in menopause: a roadmap for integrating endocrine dynamics, multisystem physiology, and precision medicine.

Maturitas·2026
Same journal

Testosterone therapy in women: Keeping pace with the evidence.

Maturitas·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy
10:59

Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy

Published on: May 28, 2021

SERMs: progress and future perspectives.

James H Pickar1, Tanya MacNeil, Kathleen Ohleth

  • 1Department of Obstetrics and Gynecology, Columbia University Medical Center, New York, NY 10032, USA. jhpickar@me.com

Maturitas
|June 29, 2010
PubMed
Summary
This summary is machine-generated.

Selective estrogen receptor modulators (SERMs) offer targeted hormone therapy for various conditions. Ongoing research aims to optimize SERMs for menopausal symptom relief and explore new applications in men.

More Related Videos

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Related Experiment Videos

Last Updated: Jun 11, 2026

Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy
10:59

Label-Free Imaging of Lipid Storage Dynamics in Caenorhabditis elegans using Stimulated Raman Scattering Microscopy

Published on: May 28, 2021

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

Area of Science:

  • Endocrinology and Pharmacology
  • Reproductive Medicine
  • Oncology

Background:

  • Selective estrogen receptor modulators (SERMs) exhibit tissue-specific agonist or antagonist activity at estrogen receptors.
  • Existing SERMs are utilized for breast cancer, osteoporosis, ovulatory dysfunction, and contraception.
  • Current treatments for menopausal symptoms are insufficient, necessitating the development of improved therapies.

Purpose of the Study:

  • To identify an optimal SERM for postmenopausal women addressing hot flushes, vaginal atrophy, and fracture prevention.
  • To ensure endometrial, breast, and cardiovascular protection with novel SERM therapies.
  • To explore future applications of SERMs, including tissue-selective estrogen complexes (TSEC) and male-specific treatments.

Main Methods:

  • Review of current literature on SERM mechanisms and clinical applications.
  • Analysis of unmet needs in menopausal symptom management.
  • Exploration of emerging SERM-based therapeutic strategies, including TSEC and male applications.

Main Results:

  • The need for a SERM that balances efficacy in relieving menopausal symptoms with safety for the endometrium, breast, and cardiovascular system is highlighted.
  • Tissue-selective estrogen complexes (TSEC) represent a promising future direction, combining SERMs with estrogens for enhanced tolerability and efficacy.
  • Potential new uses for SERMs in men, including osteoporosis and hypogonadism treatment, are under investigation.

Conclusions:

  • Further research is crucial to fully realize the therapeutic potential of SERMs.
  • Optimized SERMs and TSEC therapies hold promise for improving postmenopausal women's health.
  • SERMs may offer future treatment options for men with specific endocrine-related conditions.